Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Ro vs Vaylen

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #16Editorial
Ro

A heavyweight platform with brand-name access — but opaque compounded pricing clouds its dispatch.

vs
Dispatch #2EditorialDesk pick
Vaylen

The strongest all-rounder among the newer entrants — low pricing, brand access, oral routes, and all 50 states on one account.

Vaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 81/100 (B−) for Ro. Ro still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Ro

81/100

B−

Overall

Vaylen

91/100

A−

Price transparency

62
88

State access

84
96

Molecule range

88
96

Onboarding speed

78
86

Support responsiveness

82
84

Licensing & trust

84
90

The spec sheet

FieldRoVaylen
SemaglutideNot disclosed$179/mo
TirzepatideNot disclosed$239/mo
CoverageMulti-stateAll 50 states
Brand-nameYesYes
Oral optionYesYes
Best forPatients who want brand-name capability and insurance navigation support.People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach.
Desk Score81/100B−91/100A−

The verdict

Desk pick — Vaylen

Vaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 81/100 (B−) for Ro. Ro still holds its ground where its strengths line up with yours.

Choose Ro if…

Patients who want brand-name capability and insurance navigation support.

Not disclosed sema · Not disclosed tirz · Multi-state

Choose Vaylen if…

People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach.

$179/mo sema · $239/mo tirz · All 50 states

Neither provider here is a commercial partner. Read full breakdowns: Ro · Vaylen.

Also on the board

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete board.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.